Global X Scientific Beta Europe ETF (SCID) Stock Analysis

Global X Scientific Beta Europe ETF (SCID) Financial Services Profile

Global X Scientific Beta Europe ETF (SCID) provides exposure to European equities through a multi-factor, multi-strategy approach, tracking the Scientific Beta Extended Developed Europe Index. The fund utilizes an equal risk contribution methodology, targeting a diversified portfolio of approximately 600 European-listed common stocks.

What Is the Investment Thesis for SCID?

SCID offers a diversified approach to European equity exposure through its multi-factor, multi-strategy index. The fund's equal risk contribution methodology seeks to balance risk across different factors, potentially leading to more stable returns. However, the fund's performance is tied to the performance of the Scientific Beta Extended Developed Europe Index, making it susceptible to market fluctuations in the European equity market. With a beta of 1.06, SCID's volatility is similar to the broader market. The absence of a dividend yield may deter some income-focused investors. The fund's success hinges on the continued effectiveness of the underlying index's methodology in selecting and weighting European equities.

Based on FMP financials and quantitative analysis

SCID Key Highlights

SCID tracks the Scientific Beta Extended Developed Europe Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index.

• The fund invests at least 80% of its total assets in securities of the underlying index, including ADRs and GDRs.
• The underlying index comprises approximately 600 or less European-listed common stocks.
• SCID employs a multi-factor, multi-strategy approach, incorporating factors such as value, momentum, size, and low volatility.
• The fund has a beta of 1.06, indicating volatility similar to the market.

Who Are SCID's Competitors?

SCID is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SCID's Key Strengths?

Diversified exposure to European equities.

• Multi-factor investment approach.
• Equal risk contribution methodology.
• Tracks a well-defined index.

What Are SCID's Weaknesses?

Performance is tied to the underlying index.

• No dividend yield.
• Subject to market fluctuations in Europe.
• May have higher expense ratio than broad market ETFs.

What Could Drive SCID Stock Higher?

Increased investor interest in factor-based investing could drive inflows into SCID by Q3 2026.

• Continued recovery of the European economy may boost the performance of European equities.
• Strategic partnerships with financial advisors could expand SCID's distribution reach.

What Are the Key Risks for SCID?

Economic slowdown in Europe could negatively impact the performance of European equities.

• Increased competition from other ETFs could reduce SCID's market share.
• Changes in the underlying index methodology could affect the fund's performance.
• Regulatory changes affecting ETFs could increase compliance costs.

What Are the Growth Opportunities for SCID?

• Expansion of Factor-Based Investing: The increasing popularity of factor-based investing presents a growth opportunity for SCID. As investors seek alternatives to traditional market-cap weighted indices, SCID's multi-factor approach may attract greater interest. SCID can capitalize on this trend by highlighting the potential benefits of its equal risk contribution methodology.
• Increased Demand for European Equity Exposure: Growing investor interest in European equities could drive demand for SCID. As the European economy recovers and companies demonstrate strong earnings growth, investors may seek to increase their exposure to the region. SCID offers a diversified and strategic way to access the European equity market, potentially attracting investors looking for targeted regional exposure. The European ETF market is expected to grow at a rate of 8-10% annually over the next five years.
• Strategic Partnerships and Distribution Agreements: Forming strategic partnerships with financial advisors and wealth management platforms could expand SCID's distribution reach. By partnering with key players in the financial services industry, SCID can increase its visibility and accessibility to a wider range of investors. These partnerships can provide access to new distribution channels and help educate investors about the benefits of SCID's investment strategy. Expect partnership announcements by Q4 2026.
• Development of New ETF Products: Global X could leverage the Scientific Beta methodology to develop new ETF products targeting different regions or asset classes. By expanding its product suite, Global X can cater to a broader range of investor needs and preferences. This could involve creating ETFs focused on specific sectors within the European market or developing ETFs that combine the Scientific Beta methodology with other investment strategies. New product launches are anticipated in 2027-2028.
• Educational Initiatives and Content Marketing: Creating educational content and marketing materials that highlight the benefits of SCID's multi-factor approach can attract new investors. By educating investors about the underlying index's methodology and the potential advantages of equal risk contribution, SCID can differentiate itself from competitors and build trust with potential clients. This could involve publishing white papers, creating webinars, and developing interactive tools that demonstrate the fund's performance and risk characteristics. Ongoing content marketing efforts will be crucial for sustained growth.

What Are SCID's Competitive Advantages?

• Proprietary Index Methodology: The Scientific Beta index methodology provides a unique approach to factor-based investing.
• Established Brand: Global X has a recognized brand in the ETF market.
• Diversified Exposure: The fund offers broad exposure to European equities, reducing single-stock risk.

What Does SCID Do?

The Global X Scientific Beta Europe ETF (SCID) seeks to mirror the investment results of the Scientific Beta Extended Developed Europe Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index, before fees and expenses. The fund was created to provide investors with a strategic approach to accessing the European equity market. It achieves this by investing at least 80% of its total assets in the securities of the underlying index, including American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the index. The underlying index is composed of approximately 600 or fewer European-listed common stocks, selected using a proprietary methodology developed by the index provider, Scientific Beta. This methodology focuses on a multi-factor, multi-strategy approach, incorporating factors such as value, momentum, size, and low volatility. The ERC component aims to balance risk contributions from each factor, leading to a more diversified and potentially more stable portfolio. The fund offers investors a way to gain exposure to a broad range of European equities while employing a sophisticated investment strategy.

What Products and Services Does SCID Offer?

• Tracks the Scientific Beta Extended Developed Europe Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index.
• Invests primarily in European-listed common stocks.
• Utilizes a multi-factor investment approach.
• Employs an equal risk contribution methodology.
• Offers exposure to approximately 600 European companies.
• Provides a diversified approach to European equity investing.

How Does SCID Make Money?

• Generates revenue through management fees charged on assets under management (AUM).
• AUM grows through investment performance and net inflows.
• Fees are typically a percentage of AUM, creating a scalable revenue model.

What Industry Does SCID Operate In?

The asset management industry is characterized by a diverse range of investment products, including ETFs, mutual funds, and hedge funds. SCID operates within the ETF segment, specifically targeting investors seeking exposure to European equities through a factor-based approach. The competitive landscape includes both broad market ETFs and those employing specific investment strategies. Market trends include increasing demand for passive investment strategies and factor-based investing. SCID's multi-factor approach differentiates it from simpler market-cap weighted ETFs, but it competes with other factor-based and smart beta ETFs in the European equity space.

Who Are SCID's Key Customers?

• Retail investors seeking exposure to European equities.
• Financial advisors using ETFs in client portfolios.
• Institutional investors seeking diversified European equity exposure.

Return on equity for Global X Scientific Beta Europe ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. SCID trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

SCID Financials

SCID Latest News

No recent news available for SCID.

SCID Analyst Consensus

SCID MoonshotScore

What Investors Ask About Global X Scientific Beta Europe ETF (SCID) — Financial Services

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources